(2E)-1-(2,5-dimethoxyphenyl)-3-(quinoxalin-6-yl)prop-2-en-1-one

ID: ALA1938885

PubChem CID: 57328005

Max Phase: Preclinical

Molecular Formula: C19H16N2O3

Molecular Weight: 320.35

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(OC)c(C(=O)/C=C/c2ccc3nccnc3c2)c1

Standard InChI:  InChI=1S/C19H16N2O3/c1-23-14-5-8-19(24-2)15(12-14)18(22)7-4-13-3-6-16-17(11-13)21-10-9-20-16/h3-12H,1-2H3/b7-4+

Standard InChI Key:  BTPRTQBGYFRKOB-QPJJXVBHSA-N

Molfile:  

     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -5.3223   -5.0208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3234   -5.8482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6086   -6.2610    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6104   -4.6080    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8950   -5.0172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8943   -5.8440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1790   -6.2550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4639   -5.8402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4687   -5.0102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1846   -4.6030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7568   -4.5934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0398   -5.0015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3278   -4.5847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3891   -4.9928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3329   -3.7597    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3897   -5.8178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1059   -6.2258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8188   -5.8089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8111   -4.9797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0944   -4.5754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0858   -3.7504    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1105   -7.0508    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3983   -7.4673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7960   -3.3305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
 11 12  2  0
  5  6  1  0
 12 13  1  0
  3  6  2  0
 13 14  1  0
  6  7  1  0
 13 15  2  0
  1  2  2  0
 14 16  2  0
  7  8  2  0
 16 17  1  0
  5  4  2  0
 17 18  2  0
  8  9  1  0
 18 19  1  0
  4  1  1  0
 19 20  2  0
 20 14  1  0
  9 10  2  0
 20 21  1  0
 10  5  1  0
 17 22  1  0
 22 23  1  0
  9 11  1  0
 21 24  1  0
M  END

Associated Targets(non-human)

Mapk1 Mitogen-activated protein kinase 1 and 3 (ERK2 and ERK1) (27 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
C6 (2371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 320.35Molecular Weight (Monoisotopic): 320.1161AlogP: 3.54#Rotatable Bonds: 5
Polar Surface Area: 61.31Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.72CX LogP: 2.90CX LogD: 2.90
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.53Np Likeness Score: -0.38

References

1. Mielcke TR, Mascarello A, Filippi-Chiela E, Zanin RF, Lenz G, Leal PC, Chiaradia LD, Yunes RA, Nunes RJ, Battastini AM, Morrone FB, Campos MM..  (2012)  Activity of novel quinoxaline-derived chalcones on in vitro glioma cell proliferation.,  48  [PMID:22209415] [10.1016/j.ejmech.2011.12.023]
2. Kumar Sahoo S, Maddipatla S, Nageswara Rao Gajula S, Naiyaz Ahmad M, Kaul G, Nanduri S, Sonti R, Dasgupta A, Chopra S, Madhavi Yaddanapudi V..  (2022)  Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy.,  64  [PMID:35487101] [10.1016/j.bmc.2022.116777]

Source